Ritonavir Completed Phase N/A Trials for Human Immunodeficiency Virus (HIV) Infections

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00886990Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens
NCT00851799Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
NCT00197639Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand
NCT01606722Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy
NCT01153269Long-term Effectiveness and Safety in Hepatitis-co-infected Patients
NCT01662336Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program
NCT00666055Sex, Aging and Antiretroviral Pharmacokinetics
NCT00976950A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.
NCT00977756IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
NCT00585793Relationship Between HIV-1 Subtype and ARV Response
NCT00884793Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut
NCT00531206Observational Non-interventional Study (Anwendungsbeobachtung) With AptivusĀ® (Tipranavir) in HIV-infected Patients.
NCT01076985Special Investigation of Kaletra in Pregnant Women
NCT01076972Drug Use Investigation of Kaletra
NCT01083810Evaluation of Kaletra Therapy Over the Long-term
NCT01180075Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population
NCT02404259PK TDF in Thai HIV-infected Children